» Articles » PMID: 28123345

The Protective Effect of Alpha 7 Nicotinic Acetylcholine Receptor Activation on Critical Illness and Its Mechanism

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2017 Jan 27
PMID 28123345
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Critical illnesses and injuries are recognized as major threats to human health, and they are usually accompanied by uncontrolled inflammation and dysfunction of immune response. The alpha 7 nicotinic acetylcholine receptor (α7nAchR), which is a primary receptor of cholinergic anti-inflammatory pathway (CAP), exhibits great benefits for critical ill conditions. It is composed of 5 identical α7 subunits that form a central pore with high permeability for calcium. This putative structure is closely associated with its functional states. Activated α7nAChR exhibits extensive anti-inflammatory and immune modulatory reactions, including lowered pro-inflammatory cytokines levels, decreased expressions of chemokines as well as adhesion molecules, and altered differentiation and activation of immune cells, which are important in maintaining immune homeostasis. Well understanding of the effects and mechanisms of α7nAChR will be of great value in exploring effective targets for treating critical diseases.

Citing Articles

Multifaceted roles of mitochondria in asthma.

Zhang W, Zhang C, Zhang Y, Zhou X, Dong B, Tan H Cell Biol Toxicol. 2024; 40(1):85.

PMID: 39382744 PMC: 11464602. DOI: 10.1007/s10565-024-09928-8.


Protective role of acetylcholine and the cholinergic system in the injured heart.

Liu Chung Ming C, Wang X, Gentile C iScience. 2024; 27(9):110726.

PMID: 39280620 PMC: 11402255. DOI: 10.1016/j.isci.2024.110726.


Nicotinic receptors in airway disease.

Borkar N, Thompson M, Bartman C, Khalfaoui L, Sine S, Sathish V Am J Physiol Lung Cell Mol Physiol. 2023; 326(2):L149-L163.

PMID: 38084408 PMC: 11280694. DOI: 10.1152/ajplung.00268.2023.


The potential for traditional Chinese therapy in treating sleep disorders caused by COVID-19 through the cholinergic anti-inflammatory pathway.

Xie X, Zhang N, Fu J, Wang Z, Ye Z, Liu Z Front Pharmacol. 2022; 13:1009527.

PMID: 36299906 PMC: 9589290. DOI: 10.3389/fphar.2022.1009527.


Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?-A Narrative Review.

Lorkiewicz P, Waszkiewicz N J Clin Med. 2022; 11(20).

PMID: 36294388 PMC: 9604904. DOI: 10.3390/jcm11206060.


References
1.
Reiss L, Uhlig U, Uhlig S . Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol. 2012; 91(6-7):590-601. DOI: 10.1016/j.ejcb.2011.11.004. View

2.
Lieberman J, Dunbar G, Segreti A, Girgis R, Seoane F, Beaver J . A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology. 2013; 38(6):968-75. PMC: 3629385. DOI: 10.1038/npp.2012.259. View

3.
Terrando N, Yang T, Ryu J, Newton P, Monaco C, Feldmann M . Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice. Mol Med. 2014; 20:667-75. PMC: 4398668. DOI: 10.2119/molmed.2014.00143. View

4.
Fujii T, Horiguchi K, Sunaga H, Moriwaki Y, Misawa H, Kasahara T . SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity. J Neuroimmunol. 2013; 267(1-2):43-9. DOI: 10.1016/j.jneuroim.2013.12.003. View

5.
Johnson E, Matthay M . Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv. 2010; 23(4):243-52. PMC: 3133560. DOI: 10.1089/jamp.2009.0775. View